Key Findings:  CBD seems to be a candidate for the treatment of ASD but clinical guidance is still lacking.
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  Israel
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype III